Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by DaveInCalgaryon Feb 26, 2024 1:45pm
1691 Views
Post# 35899576

RE:RE:RE:Tilray Brands - Germany

RE:RE:RE:Tilray Brands - GermanyGermany: Fact and Fiction

Cannabis Sector Equity Research   26 February 2024

Pablo Zuanic
ZUANIC & ASSOCIATES
pablo.zuanic@zuanicgroup.com 420Odysseus;
www.zuanicassociates.com

https://zuanic.worldflowconnect.net/open/0176c2c4-ad2a-43a8-ae32-d90a3df0d0cf/240226%20Germany.pdf/07a73660-9328-46e2-9df8-6a8c563abaf9

Few remarks:
"While Friday was good for global cannabis, we are baffled by the way some stocks reacted on Friday to the news the Bundestag had approved “phase 1” (will not delve into the details). But therein lies the opportunity for shrewd long-term investors."

"According to the summary, it appears Tilray is responsible for 35% of international sales to Germany and has one of the largest shares of the German medical cannabis industry (when compared to other listed stocks), and its footprint should grow considerably with increased demand and lessened restrictions."

"They are projecting TLRY for 900M (1.21B CDN) in revenue for 2024 and 100M in EBITDA (133M CDN). On a 40x multiple like some others in the cannabis industry are getting, that would be 4B market cap and selling price of 5.30$. Jeffries and their analyst (Owen Bennett) also reiterated similar findings and had a price target of 4.30$. Only a matter of time now, TLRY investors will be vindicated.
EBITDA of 160M for 2025 is even more bullish, let's go. With a 40x multiple, that's a stock price of 8.5$."


NOTE: This Report missed the November reviews included in Friday’s vote. 
Demecan lobbied to have Govt quotas on 'In Country' licensed producers removed, strains relaxed and distribution. 
Made in Germany to reduce Foreign Imports. 
Demecan, Aurora & Tilray big improvement. Advantage.


<< Previous
Bullboard Posts
Next >>